Royal Bank of Canada’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $94.5M | Buy |
618,710
+40,788
| +7% | +$6.25M | 0.02% | 650 |
|
|
2025
Q4 | $79.7M | Buy |
577,922
+25,995
| +5% | +$3.4M | 0.01% | 740 |
|
|
2025
Q3 | $70.8M | Buy |
551,927
+48,128
| +10% | +$5.87M | 0.01% | 847 |
|
|
2025
Q2 | $61M | Sell |
503,799
-39,433
| -7% | -$4.44M | 0.01% | 844 |
|
|
2025
Q1 | $60.6M | Sell |
543,232
-47,490
| -8% | -$5.06M | 0.01% | 725 |
|
|
2024
Q4 | $57.5M | Buy |
590,722
+4,819
| +0.8% | +$514K | 0.01% | 771 |
|
|
2024
Q3 | $67.4M | Sell |
585,903
-52,742
| -8% | -$5.98M | 0.01% | 689 |
|
|
2024
Q2 | $68M | Buy |
638,645
+40,697
| +7% | +$4.09M | 0.02% | 647 |
|
|
2024
Q1 | $57.8M | Buy |
597,948
+8,587
| +1% | +$880K | 0.01% | 726 |
|
|
2023
Q4 | $59.5M | Buy |
589,361
+2,634
| +0.4% | +$254K | 0.01% | 708 |
|
|
2023
Q3 | $59.8M | Sell |
586,727
-25,347
| -4% | -$2.57M | 0.02% | 629 |
|
|
2023
Q2 | $61.8M | Sell |
612,074
-2,390
| -0.4% | -$239K | 0.02% | 627 |
|
|
2023
Q1 | $56.5M | Sell |
614,464
-4,650
| -0.8% | -$406K | 0.02% | 624 |
|
|
2022
Q4 | $56.2M | Sell |
619,114
-17,053
| -3% | -$1.44M | 0.02% | 641 |
|
|
2022
Q3 | $48.4M | Sell |
636,167
-313,859
| -33% | -$26M | 0.02% | 651 |
|
|
2022
Q2 | $80.3M | Sell |
950,026
-58,306
| -6% | -$5.12M | 0.02% | 500 |
|
|
2022
Q1 | $88.5M | Buy |
1,008,332
+21,522
| +2% | +$1.86M | 0.02% | 542 |
|
|
2021
Q4 | $86.3M | Sell |
986,810
-344,647
| -26% | -$28.6M | 0.02% | 583 |
|
|
2021
Q3 | $109M | Sell |
1,331,457
-167,130
| -11% | -$15M | 0.03% | 458 |
|
|
2021
Q2 | $137M | Sell |
1,498,587
-6,052
| -0.4% | -$539K | 0.04% | 393 |
|
|
2021
Q1 | $129M | Buy |
1,504,639
+49,506
| +3% | +$4.44M | 0.04% | 386 |
|
|
2020
Q4 | $137M | Sell |
1,455,133
-84,276
| -5% | -$7.36M | 0.04% | 371 |
|
|
2020
Q3 | $134M | Buy |
1,539,409
+37,085
| +2% | +$3.21M | 0.05% | 316 |
|
|
2020
Q2 | $131M | Buy |
1,502,324
+13,516
| +0.9% | +$1.17M | 0.05% | 296 |
|
|
2020
Q1 | $123M | Sell |
1,488,808
-15,091
| -1% | -$1.35M | 0.06% | 258 |
|
|
2019
Q4 | $142M | Buy |
1,503,899
+34,634
| +2% | +$3.11M | 0.05% | 306 |
|
|
2019
Q3 | $128M | Sell |
1,469,265
-19,216
| -1% | -$1.73M | 0.05% | 310 |
|
|
2019
Q2 | $136M | Sell |
1,488,481
-201,864
| -12% | -$17.1M | 0.05% | 284 |
|
|
2019
Q1 | $146M | Sell |
1,690,345
-4,673
| -0.3% | -$375K | 0.06% | 262 |
|
|
2018
Q4 | $130M | Buy |
1,695,018
+60,232
| +4% | +$4.69M | 0.06% | 268 |
|
|
2018
Q3 | $126M | Buy |
1,634,786
+171,828
| +12% | +$12.7M | 0.05% | 299 |
|
|
2018
Q2 | $99M | Sell |
1,462,958
-116,671
| -7% | -$8.05M | 0.04% | 330 |
|
|
2018
Q1 | $114M | Buy |
1,579,629
+50,602
| +3% | +$3.85M | 0.05% | 301 |
|
|
2017
Q4 | $115M | Buy |
1,529,027
+73,746
| +5% | +$5.56M | 0.05% | 298 |
|
|
2017
Q3 | $112M | Sell |
1,455,281
-150,678
| -9% | -$11.4M | 0.05% | 290 |
|
|
2017
Q2 | $120M | Sell |
1,605,959
-231,778
| -13% | -$16.4M | 0.06% | 259 |
|
|
2017
Q1 | $122M | Buy |
1,837,737
+153,387
| +9% | +$10.2M | 0.07% | 248 |
|
|
2016
Q4 | $110M | Buy |
1,684,350
+344,175
| +26% | +$22.3M | 0.06% | 275 |
|
|
2016
Q3 | $94.8M | Buy |
1,340,175
+50,321
| +4% | +$3.67M | 0.05% | 295 |
|
|
2016
Q2 | $95.4M | Buy |
1,289,854
+95,095
| +8% | +$6.57M | 0.06% | 269 |
|
|
2016
Q1 | $77.6M | Buy |
1,194,759
+27,077
| +2% | +$1.84M | 0.05% | 315 |
|
|
2015
Q4 | $90M | Buy |
1,167,682
+494,982
| +74% | +$39.3M | 0.06% | 263 |
|
|
2015
Q3 | $55.4M | Sell |
672,700
-58,045
| -8% | -$5.17M | 0.04% | 328 |
|
|
2015
Q2 | $64.4M | Sell |
730,745
-18,483
| -2% | -$1.7M | 0.04% | 299 |
|
|
2015
Q1 | $66.2M | Buy |
749,228
+3,488
| +0.5% | +$309K | 0.05% | 303 |
|
|
2014
Q4 | $61.9M | Buy |
745,740
+18,552
| +3% | +$1.54M | 0.04% | 355 |
|
|
2014
Q3 | $61.3M | Buy |
727,188
+12,591
| +2% | +$1.02M | 0.04% | 323 |
|
|
2014
Q2 | $58M | Buy |
714,597
+41,170
| +6% | +$3.24M | 0.04% | 335 |
|
|
2014
Q1 | $51.3M | Buy |
673,427
+56,949
| +9% | +$4.15M | 0.04% | 364 |
|
|
2013
Q4 | $44.4M | Buy |
616,478
+29,666
| +5% | +$2.06M | 0.03% | 411 |
|
|
2013
Q3 | $40.3M | Buy |
586,812
+133,671
| +29% | +$8.84M | 0.03% | 421 |
|
|
2013
Q2 | $28.7M | Buy |
+453,141
| New | +$29.5M | 0.02% | 514 |
|
Other funds holding NVS
Royal Bank of Canada's NVS Position: Q1 2026 in Review
Royal Bank of Canada increased its Novartis (NVS) stake by 7.1% in Q1 2026, buying an estimated $6.25M and bringing the position to 618,710 shares worth $94.5M. The position accounts for 0.02% of the portfolio, ranked #650.
Royal Bank of Canada first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $146M in Q1 2019. 1,594 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Royal Bank of Canada held 618,710 shares of Novartis worth $94.5M as of Q1 2026.
- Royal Bank of Canada bought 40,788 Novartis shares in Q1 2026, an estimated $6.25M.
- Novartis made up 0.02% of Royal Bank of Canada's portfolio in Q1 2026, its #650 holding.
- Royal Bank of Canada first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's Novartis position peaked at $146M in Q1 2019.
- 1,594 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.